Mind Medicine Inc (NASDAQ:MNMD) has a beta value of 2.39 and has seen 1.51 million shares traded in the last trading session. The company, currently valued at $417.54M, closed the last trade at $5.54 per share which meant it lost -$0.31 on the day or -5.30% during that session. The MNMD stock price is -120.58% off its 52-week high price of $12.22 and 9.21% above the 52-week low of $5.03. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.26 million shares traded. The 3-month trading volume is 2.00 million shares.
The consensus among analysts is that Mind Medicine Inc (MNMD) is Buy stock at the moment, with a recommendation rating of 1.36. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.37.
Mind Medicine Inc (NASDAQ:MNMD) trade information
Sporting -5.30% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the MNMD stock price touched $5.54 or saw a rise of 18.89%. Year-to-date, Mind Medicine Inc shares have moved -20.40%, while the 5-day performance has seen it change -18.29%. Over the past 30 days, the shares of Mind Medicine Inc (NASDAQ:MNMD) have changed -8.73%. Short interest in the company has seen 11.37 million shares shorted with days to cover at 4.92.
Wall Street analysts have a consensus price target for the stock at $16, which means that the shares’ value could jump 65.38% from current levels. The projected low price target is $16.0 while the price target rests at a high of $16.0. In that case, then, we find that the current price level is -188.81% off the targeted high while a plunge would see the stock gain -188.81% from current levels.
Mind Medicine Inc (MNMD) estimates and forecasts
The company’s shares have lost -5.30% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 10.40% over the past 5 years.
MNMD Dividends
Mind Medicine Inc is expected to release its next earnings report on 2025-Mar-05 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Mind Medicine Inc (NASDAQ:MNMD)’s Major holders
Insiders own 1.49% of the company shares, while shares held by institutions stand at 55.75% with a share float percentage of 56.59%. Investors are also buoyed by the number of investors in a company, with Mind Medicine Inc having a total of 229.0 institutions that hold shares in the company. The top two institutional holders are COMMODORE CAPITAL LP with over 7.15 million shares worth more than $51.52 million. As of 2024-06-30, COMMODORE CAPITAL LP held 9.9369% of shares outstanding.
The other major institutional holder is DEEP TRACK CAPITAL, LP, with the holding of over 6.1 million shares as of 2024-06-30. The firm’s total holdings are worth over $44.01 million and represent 8.4879% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Trust-iShares Russell 2000 ETF and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Feb 28, 2025 , the former fund manager holds about 2.77% shares in the company for having 2.09 shares of worth $11.56 million while later fund manager owns 988.95 shares of worth $5.48 million as of Dec 31, 2024 , which makes it owner of about 1.31% of company’s outstanding stock.
